Literature DB >> 2837370

Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference.

M Prieto1, M J Gómez-Lechón, M Hoyos, J V Castell, D Carrasco, J Berenguer.   

Abstract

The ascitic fluid concentrations of cholesterol and fibronectin and the serum-ascites albumin difference were compared with two conventional tests of ascitic fluid, total protein and LDH, in their diagnostic ability for detection of malignancy in ascitic samples from 69 patients with ascites: 54 with ascites due to liver disease and 15 whose ascites was caused by peritoneal metastases. Sixteen cirrhotic patients with superimposed hepatocellular carcinoma in whom ascites was of uncertain etiology were considered separately. The mean ascitic fluid total protein, LDH, cholesterol, and fibronectin values in the peritoneal metastases group were 3.70 +/- 1.20 g/dl, 247.26 +/- 148.14 units/liter, 109.06 +/- 29.85 mg/dl, and 91.57 +/- 41.52 micrograms/ml, respectively, and all were significantly higher than the corresponding values in the liver disease group (P less than 0.001), which were 1.37 +/- 0.59 g/dl, 75.40 +/- 110.70 units/liter, 23.75 +/- 11.22 mg/dl, and 31.86 +/- 10.51 micrograms/ml, respectively. Mean serum-ascites albumin difference in the peritoneal metastases group was 0.62 +/- 0.38 g/dl, which was significantly different from the corresponding value in the liver disease group (1.92 +/- 0.41 g/dl, P less than 0.001). Both ascitic cholesterol above 46 mg/dl and an ascitic fibronectin concentration greater than 50 micrograms/ml had high diagnostic accuracy (97%) for malignancy, being higher than that achieved using a serum-ascites albumin difference under 1.1 g/dl and an ascitic total protein above 2.5 g/dl, which had accuracies of 94% and 93%, respectively. Ascitic fluid LDH was the least reliable test. No differences in the ascitic fluid analysis were found between cirrhotic patients with and without hepatocellular carcinoma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837370     DOI: 10.1007/BF01550972

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Carcinoembryonic antigen titers on effusion fluid. A diagnostic tool?

Authors:  J S Nystrom; B Dyce; J Wada; J R Bateman; B Haverback
Journal:  Arch Intern Med       Date:  1977-07

2.  Probability theory in the use of diagnostic tests. An introduction to critical study of the literature.

Authors:  H C Sox
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

3.  High protein ascites in patients with uncomplicated hepatic cirrhosis.

Authors:  R E Sampliner; F L Iber
Journal:  Am J Med Sci       Date:  1974-05       Impact factor: 2.378

4.  Diagnostic value of the estimation of glucose in ascitic fluid.

Authors:  M Polak; A C Torres da Costa
Journal:  Digestion       Date:  1973       Impact factor: 3.216

5.  Carcinoembryonic antigen assay of ascites and detection of malignancy.

Authors:  M S Loewenstein; R A Rittgers; A E Feinerman; H Z Kupchik; B R Marcel; R S Koff; N Zamcheck
Journal:  Ann Intern Med       Date:  1978-05       Impact factor: 25.391

6.  Enzyme-linked immunosorbent assay to quantify fibronectin.

Authors:  M J Gomez-Lechon; J V Castell
Journal:  Anal Biochem       Date:  1985-02-15       Impact factor: 3.365

7.  Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels.

Authors:  T D Boyer; A M Kahn; T B Reynolds
Journal:  Arch Intern Med       Date:  1978-07

8.  Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites.

Authors:  D Jüngst; A L Gerbes; R Martin; G Paumgartner
Journal:  Hepatology       Date:  1986 Mar-Apr       Impact factor: 17.425

9.  Crosslinked fibrin derivatives and fibronectin in ascitic fluid from patients with ovarian cancer compared to ascitic fluid in liver cirrhosis.

Authors:  R Hafter; W Klaubert; R Gollwitzer; R von Hugo; H Graeff
Journal:  Thromb Res       Date:  1984-07-01       Impact factor: 3.944

10.  White count, pH and lactate in ascites in the diagnosis of spontaneous bacterial peritonitis.

Authors:  C Y Yang; Y F Liaw; C M Chu; I S Sheen
Journal:  Hepatology       Date:  1985 Jan-Feb       Impact factor: 17.425

View more
  11 in total

1.  Discrimination between malignant and nonmalignant ascites using serum and ascitic fluid proteins in a multivariate analysis model.

Authors:  M G Alexandrakis; J A Moschandrea; S A Koulocheri; E Kouroumalis; G D Eliopoulos
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

2.  Biomarkers of malignant ascites-a myth or reality: Reply.

Authors:  Mithu Banerjee
Journal:  Med J Armed Forces India       Date:  2016-05-30

3.  Ascitic cholesterol: accurate parameter to the differential diagnosis of ascites?

Authors:  J E Pina-Babral; M Correia-Leitão; C Guerra; L Tomé; M L Pinto; D Costa; J Gouveia-Monteiro
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

4.  Ascitic fluid alpha 1-antitrypsin.

Authors:  F G Villamil; P B Sorroche; H F Aziz; P M Lopez; J M Oyhamburu
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

5.  Serum-ascites albumin gradients in nonalcoholic liver disease.

Authors:  M A Kajani; Y K Yoo; J A Alexander; J S Gavaler; R E Stauber; V J Dindzans; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

6.  Biomarkers of malignant ascites-a myth or reality.

Authors:  Mithu Banerjee; Rajeshwar Singh; M M Arora; V Srinivas; D Basannar; Seema Patrikar
Journal:  Med J Armed Forces India       Date:  2011-07-21

7.  Diagnostic accuracy of ascitic cholesterol concentration for malignant ascites: a meta-analysis.

Authors:  Hong Zhu; Yongchun Shen; Kai Deng; Xia Liu; Yaqin Zhao; Taiguo Liu; Ying Huang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  New Biochemical Parameters in the Differential Diagnosis of Ascitic Fluids.

Authors:  Anabela Angeleri; Adriana Rocher; Beatriz Caracciolo; Marcela Pandolfo; Luis Palaoro; Beatriz Perazzi
Journal:  Gastroenterology Res       Date:  2016-03-08

9.  Polysaccharides Extracted from Rhizoma Pleionis Have Antitumor Properties In Vitro and in an H22 Mouse Hepatoma Ascites Model In Vivo.

Authors:  Yukun Fang; Anhong Ning; Sha Li; Shaozheng Zhou; Lei Liu; Thomson Patrick Joseph; Mintao Zhong; Jilong Jiao; Wei Zhang; Yonghui Shi; Meishan Zhang; Min Huang
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

10.  Malignant Peritoneal Mesothelioma Presenting with High Protein, High Serum-Ascites Albumin Gradient.

Authors:  Zachary P Kerosky; Charleston R Powell; Phillip C Lindholm
Journal:  Cureus       Date:  2022-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.